INMB: INmune Bio Inc Kompaniya qiymatining sof foydaga nisbati
INmune Bio, Inc. (INMB) dori ishlab chiqarishni uchinchi tomon pudratchilariga topshirish orqali atrof-muhitga bo'lgan ta'sirini minimallashtiradi. Biznes shifoxonalar tarmog'i orqali demensiya va onkologiyaga qarshi kurashish uchun tug'ma immun tizimini qayta dasturlashga e'tibor qaratadi. -1.80 ko'rsatkichi bo'lgan qimmatqimmatli qog'ozlarning narx dinamikasi sinov natijalari bo'yicha noaniqlik, intensiv kapital xarajatlar va bozorning eng yirik texnologik gigantlarining tajovuzkor bosimi tufayli yuzaga kelgan tebranishlarni namoyish etmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_INMB_-_INmune-Bio-Inc._-_PE-Multiple "INMB: INmune Bio, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
INmune Bio Corp (INMB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati INmune Bio, Inc.|INMB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati INmune Bio Corporation|INMB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati INmune Bio, Inc.|INMB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz INmune Bio|Oraliq qoplama koeffitsiyenti inmunebio.com
- foyda va bozor multiplikatorlari tafsilotlari:
INMB - Kompaniyaning sof foydasi|Sof foyda prognozi INmune Bio, Inc.|INMB - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati INmune Bio Inc|INMB - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori INmune Bio, Inc.|INMB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda INmune Bio|INMB - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi inmunebio.com|INMB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi INmune Bio, Inc.
Kompaniyaning har tomonlama tahlili:inmunebio.com INMB
P/E koeffitsiyenti foydaning bir birligining bozor qiymatini aks ettiradi va bu aktivning daromad keltirish qobiliyatiga nisbatan haddan tashqari qimmat yoki arzon baholanganligini baholash imkonini beradi. INmune Bio, Inc. (INMB) kompaniyasining tarixiy o'rtacha P/E koeffitsiyentini tahlil qilish orqali investor biotexnologiya sektorining o'ziga xos jihatlarini kuzatadi: R&D xarajatlari tufayli daromadning yo'qligi ushbu metrikani rasman qo'llash imkonini bermaydi, natijada bozor kapitalizatsiyasi kompaniya dori vositalarining kelgusidagi muvaffaqiyatiga tikilgan garovga aylanadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tourmaline TRML|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Narx-foyda multiplikatori PHAR|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narx-foyda koeffitsiyenti Upstream Bio, Inc. (UPB)|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|KALV: Narx-foyda multiplikatori|Septerna - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|Narxning foydaga nisbati ATXS|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|KYTX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|VTYX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Theratechnologies Inc|Narx-foyda multiplikatori AVTX (Avalo Therapeutics Inc)|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|Climb Bio - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|aTyr - P/E multiplikatori|Biznesning o‘zini qoplash muddati Adagene ADAG|ikenaoncology.com (IMA) - Narxning foydaga nisbati|Narx-foyda multiplikatori STTK|Narxning foydaga nisbati Equillium Inc|Narx-foyda koeffitsiyenti Connect Pharma (CNTB)|P/E multiplikatori IMUX|Narxning foydaga nisbati ATRA (atarabio.com)|Narxning foydaga nisbati InflaRx IFRX|XFOR (x4pharma.com) - Kapitalizatsiyaning sof foydaga nisbati|Adicet - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CELU (Celularity Inc.)|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|AKTX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTLB: P/E multiplikatori|BOLT - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|GRI Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND - Narxning foydaga nisbati|REVB (Revelation Biosciences Corp) - Narx-foyda multiplikatori|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
